{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:06:18Z","timestamp":1792166778570,"version":"4.4.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.juro.2008.08.006","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T06:00:22Z","timestamp":1229493622000},"page":"2379-2383","source":"Crossref","is-referenced-by-count":137,"title":["Phase I\/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin"],"prefix":"10.1097","volume":"180","author":[{"given":"Abraham Ami","family":"Sidi","sequence":"first","affiliation":[{"name":"Department of Urologic Surgery, Edith Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Holon, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ohana","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Institute of Life Sciences, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalva","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, Edith Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Holon, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Shalev","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, Meir Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Kfar Saba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet H.","family":"Ransom","sequence":"additional","affiliation":[{"name":"Fast-Track Drugs and Biologics L. L. C., North Potomac, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lamm","sequence":"additional","affiliation":[{"name":"BCG Oncology, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Hochberg","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Institute of Life Sciences, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Leibovitch","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, Meir Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Kfar Saba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2008.08.006_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2008.08.006_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)66440-3","article-title":"Cystectomy for bladder cancer: a contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.08.006_bib3","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.08.006_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.6004\/jnccn.2006.0083","article-title":"Bladder cancer","volume":"4","author":"Montie","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.juro.2008.08.006_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/nar\/29.1.189","article-title":"The non-coding RNAs as riboregulators","volume":"29","author":"Erdmann","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.juro.2008.08.006_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0090-4295(95)80030-1","article-title":"The imprinted H19 gene as a tumor marker in bladder carcinoma","volume":"45","author":"Ariel","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.juro.2008.08.006_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/mp.50.1.34","article-title":"The product of the imprinted H19 gene is an oncofetal RNA","volume":"50","author":"Ariel","year":"1997","journal-title":"Mol Pathol"},{"key":"10.1016\/j.juro.2008.08.006_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00019606-199702000-00004","article-title":"Genomic imprinting and the endometrial cycle","volume":"6","author":"Ariel","year":"1997","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.juro.2008.08.006_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/mp.51.1.21","article-title":"Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma","volume":"51","author":"Ariel","year":"1998","journal-title":"Mol Pathol"},{"key":"10.1016\/j.juro.2008.08.006_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/mp.53.6.320","article-title":"The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma","volume":"53","author":"Ariel","year":"2000","journal-title":"Mol Pathol"},{"key":"10.1016\/j.juro.2008.08.006_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I","article-title":"Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection","volume":"91","author":"Ariel","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.juro.2008.08.006_bib12","first-page":"1","article-title":"The oncofetal H19 RNA in human cancer, from the bench to the patient","volume":"3","author":"Matouk","year":"2005","journal-title":"Cancer Ther"},{"key":"10.1016\/j.juro.2008.08.006_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(95)01074-O","article-title":"The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma","volume":"374","author":"Elkin","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.juro.2008.08.006_bib14","first-page":"181","article-title":"Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer","volume":"8","author":"Ohana","year":"2004","journal-title":"Gene Ther Mol Biol"},{"key":"10.1016\/j.juro.2008.08.006_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1078-1439(01)00157-0","article-title":"Ethical issues in the use of tumor marker in clinical investigation of the management of bladder cancer","volume":"7","author":"McCullough","year":"2002","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2008.08.006_bib16","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1200\/JCO.2002.02.066","article-title":"Phase I trial of intravesical gemcitabine in bacillus Calmette-Guerin-refractory transitional-cell carcinoma of the bladder","volume":"20","author":"Dalbagni","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2008.08.006_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.ju.0000150425.09317.67","article-title":"Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer\u2013Genito-Urinary Group Phase III Trial (30906)","volume":"173","author":"de Reijke","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.08.006_bib18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.juro.2006.06.007","article-title":"Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response","volume":"176","author":"van der Heijden","year":"2006","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534708020594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534708020594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2008.08.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:42:34Z","timestamp":1651196554000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2008.08.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1016\/j.juro.2008.08.006"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2008.08.006","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}